Prokaryotic expression, purification and functional characterization of recombinant human RIP2

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Receptor-interacting protein 2 (RIP2) is a key regulator in innate and adaptive immunity.
• RIP2 influences NF-κB activation and cell death pathways.
• Investigating RIP2's in vitro biological activity necessitates substantial purified protein.

Purpose of the Study:

• To clone, express, and purify recombinant human RIP2 (rhRIP2).
• To investigate the in vitro biological functions of rhRIP2.
• To elucidate RIP2's role in differential cancer cell signaling and proliferation.

Main Methods:

• Full-length human RIP2 cloned into a pET22b prokaryotic expression vector.
• Recombinant plasmid transformed into E. coli BL21 (DE3) for IPTG-induced expression.
• Protein purification using His Trap FF crude chromatography; purity assessed by SDS-PAGE.
• MTT assays and NF-κB pathway analysis in MCF7 and Ramos cell lines.

Main Results:

• Soluble rhRIP2 expressed and purified to 90% purity.
• rhRIP2 inhibited MCF7 cell proliferation but promoted Ramos cell proliferation.
• rhRIP2 suppressed canonical NF-κB in MCF7 cells and activated non-canonical NF-κB in Ramos cells.

Conclusions:

• RIP2 exhibits functional diversity and differential effects on cancer cell lines in vitro.
• RIP2 modulates distinct NF-κB signaling pathways (canonical vs. non-canonical) depending on the cellular context.
• These findings provide novel insights into RIP2's mechanisms in tumorigenesis.